| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33e0cb77260827966a920f9232dfb4f9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-065 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5073 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ad15f9251a2ea7929c368387a1d5d5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d96d587dc25a20ecc3f9eacf7f659e3 |
| publicationDate |
2017-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017260510-A1 |
| titleOfInvention |
Leukaemia stem cell line, its method of production and uses thereof |
| abstract |
Bromodomain and extra terminal protein (BET) resistant leukemic cell lines and methods for producing such cell lines are described as are methods for using such cell lines in screening assays to identify therapeutic agents. The cell lines can be generated from haematopoietic stem and progenitor cells (HSPCs) that are clonally enriched by serially exposing c-kit positive cells to a BET inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10532054-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10131640-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10882828-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111885-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11407719-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10772894-B2 |
| priorityDate |
2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |